Current Report Filing (8-k)
June 25 2020 - 07:06AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 24, 2020
VERUS
INTERNATIONAL, INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-34106
|
|
11-3820796
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
9841
Washingtonian Boulevard, #390
Gaithersburg,
MD 20878
(Address
of principal executive offices) (zip code)
(301)
329-2700
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act: None.
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item
7.01 Regulation FD Disclosure.
On
June 24, 2020, Verus International, Inc. (the “Company”) held a scheduled earnings call for its analysts and investors,
wherein, among other business matters discussed, an announcement was made regarding the Company’s newest operating division,
Pachyderm Labs, which will target the consumer cannabidiol (“CBD”) products market. The division will operate out
of the Company’s Houston, Texas location, which will operate as both a manufacturing and warehouse facility.
Item
8.01 Other Events.
On
June 25, 2020, the Company issued a press release announcing its newest operating division, Pachyderm Labs.
The
foregoing description of the press release is only a summary and is qualified in its entirety by reference to the complete text
of the press release, which is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is hereby incorporated herein
by reference.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Verus
International, Inc.
|
|
|
Dated:
June 25, 2020
|
/s/
Anshu Bhatnagar
|
|
Anshu
Bhatnagar
|
|
Chief
Executive Officer
|
Verus (CE) (USOTC:VRUS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Verus (CE) (USOTC:VRUS)
Historical Stock Chart
From Mar 2023 to Mar 2024